AH Equity Partners Bio II, L.L.C., 10% Owner at Nautilus Biotechnology, Inc. (NAUT), sold 5,000,000 shares at $2.35 ($11.8M) on 2026-06-02, disclosed to the SEC on 2026-06-04.
Open-market sale of $11.8M NAUT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.35 | 384,026 | $902K | 7.7% |
| 2 | $2.35 | 4,615,974 | $10.8M | 92.3% |
| Total | $2.35 avg | 5,000,000 | $11.8M | 100% |